The effect of long-term amiodarone administration on myocardial fibrosis and evolution of left ventricular remodeling in a porcine model of ischemic cardiomyopathy

SpringerPlus

Table 3 Levels of circulating BNP and MMP9

Biochemical parameters	Group	Mean ± SD	p value
BNP (baseline)	Amiodarone	460.19 ± 489.93 pg/ml	0.345
BNP (baseline)	Control	206.89 ± 71.94 pg/ml	0.345
MMP9 (baseline)	Amiodarone	3508.44 ± 964.32 ng/ml	0.387
MMP9 (baseline)	Control	4832.00 ± 3073.02 ng/ml	0.387
BNP (1 month)	Amiodarone	242.59 ± 171.63 pg/ml	0.066
BNP (1 month)	Control	51.21 ± 26.65 pg/ml	0.066
MMP9 (1 month)	Amiodarone	4363.77 ± 2404.90 ng/ml	0.406
MMP9 (1 month)	Control	6443.99 ± 4575.34 ng/ml	0.406
BNP (3 months)	Amiodarone	341.90 ± 285.81 pg/ml	0.447
BNP (3 months)	Control	202.05 ± 216.96 pg/ml	0.447
MMP9 (3 months)	Amiodarone	9181.24 ± 5077.68 ng/ml	0.714
MMP9 (3 months)	Control	7681.73 ± 6773.95 ng/ml	0.714